Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bravo. Well said stevenrisk. Consider this my me too post for those counting.
Boom Burke delivers. Has delivered on everything he had said thus far since becoming CEO. Focus was developing a viable platform. Now loyalty services will be provided to dispensaries free of charge! This will be game changing software. Burke’s mission now is market penetration.
You have members pumping the stock on other stock boards. Beware they about to do the dump on MYM in my opinion since they’ve made so much money on this one.
Mods please delete. Pumping other tickers shouldn’t be allowed.
Thanks
News...EVIO Inc. To Purchase Licensed Cannabis Laboratory In Northern California.
News on technical420.com
Can’t post the link from my phone
I asked WW if he could share any insight on goals for the capital (e.g. is it targeted for expansion in Canada) and his perception of the terms for long-term shareholder value. His response...
The board is focused on executing our California growth strategy and maximizing shareholder value.
As a shareholder, I am thrilled the company can now work with traditional investment banks to raise capital for EVIO. This would not have been possible before the reverse stock split. We are continuing to work with our Canadian Securities attorney to evaluate additional financing and growth options for EVIO.
Will
WW emailed me back. his response....
We have engage Dominick Capital Corporation to raise capital for EVIO Inc,
they are only licensed in Canada and can only raise capital from Canadian
investors. The capital will be provided to EVIO Inc. (OTCQB: EVIO) so that
we can execute our business plans. Regarding warrants, they would be issued
in EVIO Common Stock upon conversion, EVIO would receive the $0.80 upon
conversion. As such all prices reflected are US Currency.
No idea. I called EVIO and asked for IR. They said WW is traveling today. I emailed WW asking if these warrants are for the Canadian exchange only. I will post any response if I get one.
For Canada Only is the way I read it...
These securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered or sold in the United States or to a U.S. persons (as defined in Regulation S under the U.S. Securities Act) absent registration or an applicable exemption from registration requirements.
First Barchart Buy Indicator I've seen for EVIO in a while Barchart Buy Opinion EVIO
FWIW In his email response to me on 11/17 he mentioned "I'm excited to focus more on market expansion as opposed to tech development once we launch before the year's end."
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=136293017
Colorado launch by year end was communicated by Burke
Received the Dr. Hemps promo via CT and ordered CBD Capsules. Technology worked and was easy to use.
US record $7.9B in online sales on Black Friday and Thanksgiving, up 17.9% from a year ago, according to Adobe Analytics. Cyber Monday is expected to drive $6.6B in internet sales, which would make it the largest U.S. online shopping day in history.
Lets apply these online sales metrics to mobile marketing and the future of Cannabis sales. Send the SMS text using CT, get your discount and pick up at your dispensary or have it delivered to your door.
Q. How will Cannabis brands become household names with limited channels for communication (no tv, radio, facebook, twitter)? A. Market through Citizen Toke.
Look at the advertising restrictions in CA. Q. How can you market Cannabis to a defined market of customers over 21? A. Citizen Toke ..Link to CA BCC
§ 5040. Advertising Placement (a) Any advertising or marketing placed in broadcast, cable, radio, print, and digital communications shall only be displayed where at least 71.6 percent of the audience is reasonably expected to be 21 years of age or older, as determined by reliable up-to-date audience composition data. (b) Upon request, a licensee shall provide to the Bureau audience composition data as required in subsection (a) of this section for advertising or marketing placed by the licensee. This information shall be provided to the Bureau within the time specified by the Bureau. (c) If the Bureau determines that audience composition data for advertising or marketing provided by a licensee, does not comply with the requirements of subsection (a) of this section, or the licensee fails to provide audience composition data to the Bureau within the time specified by the Bureau, the licensee shall remove the advertising or marketing placement in question. Authority: Section 26013, Business and Professions Code. Reference: Section 26151 and 26152, Business and Professions Code.
§ 5041. Age Confirmation in Advertising
(a) Prior to any advertising or marketing from the licensee involving direct, individualized communication or dialog, the licensee shall use age affirmation to verify that the recipient is 21 years of age or older.
(b) For the purposes of this section, direct, individualized communication or dialog, may occur through any form of communication including: in person, telephone, physical mail, or electronic.
(c) A method of age verification is not necessary for a communication if the licensee can verify that the licensee has previously had the intended recipient undergo a method of age affirmation and the licensee is reasonably certain that the communication will only be received by the intended recipient.
(d) A licensee shall use a method of age affirmation before having a potential customer added to a mailing list, subscribe, or otherwise consent to receiving direct, individualized communication or dialog controlled by a licensee.
CA Testing Requirements...All Cannabis harvested after 1/1/2018 must be tested for certain analytes, which includes Cannabinoids, Moisture content, Category II Residual Solvents, Category I Residual Pesticides, Microbial Impurities, Homogeneity; 7/1/2018 includes certain solvents, pesticides, and foreign materials; 12/31/2018 includes Terpenoids, Mycotxins,Heavy Metals, and Water Activity.
Link To CA BCC
§ 5715. Phase-In of Required Laboratory Testing (a) Cannabis and cannabis products shall not be sold or transferred to a retailer, or released for retail sale, unless a representative sample of the cannabis or cannabis product has undergone and passed all testing as required by this section. (b) All cannabis harvested on or after January 1, 2018 and all cannabis products manufactured on or after January 1, 2018 shall be tested for the following analytes, if applicable: (1)Cannabinoids as required in section 5724 of this division; (2)Moisture content as required in section 5717 of this division; (3)Category II Residual Solvents and Processing Chemicals as required in section 5718 of this division; (4)Category I Residual Pesticides as required in section 5719 of this division;
(5)Microbial Impurities as required in section 5720 of this division; and (6)Homogeneity as required in section 5716 of this division. (c) In addition to the requirements of subsection (b) of this section, all cannabis harvested on or after July 1, 2018 and all cannabis products manufactured on or after July 1, 2018 shall be tested for the following analytes, if applicable: (1)Category I Residual Solvents and Processing Chemicals as required in section 5718 of this division; (2)Category II Residual Pesticides as required in section 5719 of this division; and (3)Foreign Material as required in section 5722 of this division. (d) In addition to the requirements in subsection (b) and (c) of this section, all cannabis harvested on or after December 31, 2018 and all cannabis products manufactured on or after December 31, 2018 shall be tested for the following analytes, if applicable: (1)Terpenoids as required in section 5725 of this division; (2)Mycotoxins as required in section 5721 of this division; (3)Heavy Metals as required in section 5723 of this division; and (4)Water Activity as required in section 5717 of this division. (e) Licensees to have a sample of cannabis or cannabis products tested for analytes that are not required to be tested. However, if the sample fails the additional test(s), the batch from which the sample was collected fails testing and shall not be released for retail sale Authority: Section 26013, Business and Professions Code. Reference: Sections 26070, 26100 and 26104, Business and Professions Code.
How about if Patrick Burke answers your questions...I emailed him 11/17 and asked numerous questions and he responded.
So to answer your questions the best I can....
- White paper will be updated with full commercial release of platform... I realize that we used the term alpha which could be misinterpreted as 'going backwards'. I assure you, we are moving forward with a full commercial release in CO.
- Number of partners on the platform is a metric we will include in the updated whitepaper. Monetization? YES. We had our first paid blast with Flora's mercantile, which was mentioned in a previous PR.
- Yes
- As mentioned in the latest PR, we are looking at other states right now based on their market growth stage to find a good fit with the CT tech.
- This was a question we outlined in the white paper. Basically, users will join if they can get the best deals specific to their location with at least some brand name dispensaries that they recognize -> helps build trust, so they are more willing to try dispensaries and products they do not know. The other piece of this equation is if dispensaries/brands/ products will use the CT platform. They need a large, scalable user base that is engaged. So this is the chicken-egg paradox that we are wrestling. Experimenting with market penetration on this through various channels was part of the Beta. We have a better idea of how to approach this on both sides (user and cannabis retailer/product). I'm excited to focus more on market expansion as opposed to tech development once we launch before the year's end.
I'm happy with our progress. We've moved from idea, to minimal viable product, to beta testing, to proof of concept, to first revenues, and soon to be full release. Obviously, there have been some departures from the original business plan, but we are updating everyone as we move forward. Another PR will accompany the full release and white paper edits. Hope this helps.
Best,
Patrick
Citizen Toke full launch will be the catalyst that will move this to .01. Great odds for those willing to take the risk
San Francisco Muni Bans Cannabis Ads on Its Buses link...The opportunities for Citizen Toke are plentiful . Full product release by year-end and then we grow the end user-base and dispensary/brand base.
Patrick Burke is very responsive, engaged, and is executing the business plan. I emailed him this morning and he responded back this afternoon.
My email: A few follow up questions from your note to shareholders:
When will the white paper be updated with the developments added to the platform based upon the feedback from your Beta partners?
How many select partners have been given full access to the CT platform? Is anyone paying for the CT Platform yet? When do you foresee monetization?
Will you be providing updated metrics referenced from the white paper on blasts sent by month, results, # of dispensaries signed up etc.?
Will the CT platform be leveraging the Duby users?
Have you signed with any marketing partners in other recreational states yet?
What’s your confidence level once CT is launched that market penetration can be achieved quickly?
Patrick's response....
So to answer your questions the best I can....
- White paper will be updated with full commercial release of platform... I realize that we used the term alpha which could be misinterpreted as 'going backwards'. I assure you, we are moving forward with a full commercial release in CO.
- Number of partners on the platform is a metric we will include in the updated whitepaper. Monetization? YES. We had our first paid blast with Flora's mercantile, which was mentioned in a previous PR.
- Yes
- As mentioned in the latest PR, we are looking at other states right now based on their market growth stage to find a good fit with the CT tech.
- This was a question we outlined in the white paper. Basically, users will join if they can get the best deals specific to their location with at least some brand name dispensaries that they recognize -> helps build trust, so they are more willing to try dispensaries and products they do not know. The other piece of this equation is if dispensaries/brands/ products will use the CT platform. They need a large, scalable user base that is engaged. So this is the chicken-egg paradox that we are wrestling. Experimenting with market penetration on this through various channels was part of the Beta. We have a better idea of how to approach this on both sides (user and cannabis retailer/product). I'm excited to focus more on market expansion as opposed to tech development once we launch before the year's end.
I'm happy with our progress. We've moved from idea, to minimal viable product, to beta testing, to proof of concept, to first revenues, and soon to be full release. Obviously, there have been some departures from the original business plan, but we are updating everyone as we move forward. Another PR will accompany the full release and white paper edits. Hope this helps.
Best,
Patrick
Still many of us holding millions of shares and planning on holding thru 2018 and beyond. Burke is executing his business plan and building the capability so CT will scale as they grow. Just a matter of time and MJTK will grow and prosper.
Step 1 - leave the EVIO board
Step 2 - form your testing company and raise funds
Step 3 - come back to the board and post your ticker and I'll buy it
Step 4 - don't come back until you've successfully launched your company
I think you'll find being a keyboard CEO is a little easier
Nice recap for any new investors/prospects. Longs are holding and patient as the company continues to execute the business plan.
WW has followed through with his commitments, and he provided a PR to update shareholders. No reason he won't provide the numbers next week as stated. Added 4K shares and will continue to be optimistic the pps will rise as we continue to move foreword, get the ticker change, build the EVIO brand and hopefully get institutional investors on board.
Investment is speculative. PAOG is doing what they say they are going to do. Thus far they've executed against their plan and there is no reason to believe they won't continue to execute in the future.
From their last PR....
PAO Group is thrilled to announce that its Alternative Medicine Centers of America has opened its Parma/Cleveland location and it is now fully operational and booking appointments. In addition to the recently announced Corporate locations in Dayton and Toledo, Ohio, PAO is planning for additional subsequent Corporate locations in Columbus and Akron-Canton, Ohio.
"We are well ahead of our timeline goals in Ohio which has allowed us to be equally assertive with efforts in Florida. We have just signed a Letter of Intent with the Physicians Group working with us in Toledo, Dayton and Parma/Cleveland, for a location in Daytona, Florida. This is just days after a fully executed agreement with the group to staff our locations in St. Augustine, Jacksonville and Palm Beach County, Florida. All locations will be Corporate owned Alternative Medicine Centers of America. We are also looking at additional sites for locations in Central and South Florida."
Alternative Medicine will continue to gain momentum and this is a young and growing business that is steadily opening new locations and executing their business plan in new MMJ states.
Others are working hard to project uncertainty and act like they're experts in creating and running emerging growth businesses in the alternative medical arena and in their spare time they tell investors about it on ihub. Give me a break.
If the company continues to execute their business plan, I am confident that they will succeed over then long run.
Go PAOG.
I am willing to bet you're wrong. Here's the difference my money is where my mouth is. 4M shares. Your bet is a sentence on iHub message board. Now that's skin in the game.
Great article to increase the awareness of $PAOG. As we officially open more clinics and get more local articles and hopefully some day national articles this will increase exponentially.
Well said GM. I know I'm holding long and am looking forward to seeing a steady climb in to 2018. PAOG
Well said Penjamin. Feel the same and have no problem waiting until the software is ready before it is officially launched. Time will tell but i remain positive that it will ultimately pay off.
Nice steady climb as management continues to execute the business plan. Nice to see the new shareholders here. Go $PAOG. Keep on climbing.
Strong Day. 10M plus shares traded with a tight float. If the longs hold the float tight over the next several months the true value will be realized by the market and we will see awesome gains.
Own the float article was a great read. Will definitely get new eyes on PAOG. My shares are locked.
Love the timing of the PR's. Frequent enough to keep shareholders informed and excited and they contain substance. Kudos to Mr. Weber. Everyday we continue to grow and get more eyes on PAOG the PPS will realize and hold steady gains.
PAOG continues to execute their plan ahead of schedule. Won't be long until the market realizes this is under-valued. Continue to add shares along the way.
Vision...$PAOG. I can buy a profitable company today at 1.5 cents that will have at least 7 corp clinics and 3 affiliates open be EOY. Sounds like a winner!
You too OSU. Buckeye for life. Live in suburb of Columbus and love that PAOG is making waves in Ohio. O-H-I-O
With the great Q2 and all the clinics in the pipeline PAOG should hit a lot of radars. Love the execution, momentum, and potential growth. Go PAOG